Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
Padmanee Sharma(The University of Texas MD Anderson Cancer Center), Margitta Retz(Klinikum rechts der Isar), Arlene O. Siefker‐Radtke(The University of Texas MD Anderson Cancer Center), Ari David Baron(California Pacific Medical Center), Andrea Necchi(Fondazione IRCCS Istituto Nazionale dei Tumori), Jens Bedke(University of Tübingen), Elizabeth R. Plimack(Fox Chase Cancer Center), Daniel A. Vaena(University of Iowa), Marc‐Oliver Grimm(Jena University Hospital), Sergio Bracarda(Ospedale San Donato), José Ángel Arranz(Hospital General Universitario Gregorio Marañón), Sumanta K. Pal(City of Hope), Chikara Οhyama(Hirosaki University), Abdel Saci(Bristol-Myers Squibb (United States)), Xiaotao Qu(Bristol-Myers Squibb (United States)), Alexandre Lambert(Bristol-Myers Squibb (Belgium)), Suba Krishnan(Bristol-Myers Squibb (United States)), Alex Azrilevich(Bristol-Myers Squibb (United States)), Matthew D. Galsky(Tisch Cancer Institute)
Cited by 1,740
Abstract
Related Papers
No related papers found
Powered by citation graph analysis